Attitude of infectious diseases physicians in Turkey about HIV pre-exposure prophylaxis: results of an online survey

Cimen, Cansu; Emecen, Ahmet Naci; Barber, Tristan

doi:10.1177/0956462420921080

Cited by 4 publications

(3 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Finally, 44 original studies represented in 45 peer‐reviewed articles were included. See Figure 1 [10–42] [43–53].…”

Section: Resultsmentioning

confidence: 99%

“…Knowledge of PrEP was low, and there was no national guideline. Physicians had concerns about effectiveness, increased STIs, and cost [53].…”

Section: Resultsmentioning

confidence: 99%

“…The remaining studies did not include recipients or potential recipients of PrEP: six studies looked at healthcare professionals' opinions and behaviours for prescribing PrEP to women (6/44 [13.6%]) [46,52,53,55,56,57], public opinion with regards to PrEP (2/44 [4.5%]) [49,58], and a hypothetical PrEP impact model (1/44 [2.3%]) [17] (Hahn).…”

Section: Description Of Included Studiesmentioning

confidence: 99%

See 2 more Smart Citations

PrEP for women in Europe: a systematic literature review

et al. 2023

View full text Add to dashboard Cite

Background: Prevention of HIV transmission is fundamental to ending the HIV epidemic. Pre-exposure prophylaxis (PrEP) with oral tenofoviremtricitabine (TDF-FTC) is an established HIV-prevention method; however, most PrEP services in Europe have been targeted at men who have sex with men (MSM). A survey in 2021 by Women Against Viruses in Europe (WAVE) showed considerable variation in PrEP access and guidance for women throughout Europe. WAVE therefore commissioned this systematic review to provide insight into PrEP provision and barriers to uptake for women in Europe.Methods: PubMed, Embase, and Scopus were searched for studies (January 2013-May 2021) that reported on actual (e.g., efficacy and safety) or hypothetical (e.g., awareness, barriers, PrEP impact models) use of oral PrEP involving women (including cis, transgender, pregnant, migrant, and breastfeeding women). Search terms included HIV, pre-exposure prophylaxis (specifically TDF-FTC), and women. Studies performed outside of the World Health Organization European region were excluded. Results:The search identified 4716 unique citations, and 45 peer-reviewed articles (44 studies) were included. The majority of these studies (34/44 [77%])

show abstract

“…Finally, 44 original studies represented in 45 peer‐reviewed articles were included. See Figure 1 [10–42] [43–53].…”

Section: Resultsmentioning

confidence: 99%

“…Knowledge of PrEP was low, and there was no national guideline. Physicians had concerns about effectiveness, increased STIs, and cost [53].…”

Section: Resultsmentioning

confidence: 99%

Section: Description Of Included Studiesmentioning

confidence: 99%

See 1 more Smart Citation

PrEP for women in Europe: a systematic literature review

et al. 2023

View full text Add to dashboard Cite

show abstract

Perceived Access to HIV Prevention Services Amidst the COVID-19 Pandemic Among Men Who Have Sex with Men (MSM) and MSM Sex Workers in France, Russia, and Türkiye

Jackson,

Sullivan,

Howell

et al. 2024

Arch Sex Behav

View full text Add to dashboard Cite

This study examined the association between self-identification as a sex worker (SW) and perceived access to pharmacologic and non-pharmacologic HIV prevention methods among MSM in France, Russia, and Türkiye amidst the COVID-19 pandemic. Globally, 17,250 MSM recruited through a geosocial networking smartphone application completed the COVID-19 disparities survey, which was administered between October and November 2020. Approximately 38% of survey respondents were identified as living in France (n = 1269), Russia (n = 3882), and Türkiye (n = 3141) at the time of survey completion. Given the diverse sociodemographic factors and attitudes toward both MSM behavior and commercial sex work in these countries, we conducted a secondary analysis of survey data exploring the relationship between SW status and perceived access to pharmacologic and non-pharmacologic HIV prevention methods during the COVID-19 pandemic. Among respondents in Russia and France, MSM SW status was associated with a reduction in perceived access to condoms/lubricants (p = .001 in Russia, p < .001 in France). MSM SW in France were less likely to report never using PrEP as compared to non-SW peers (RR = 0.40, p = .005). Our findings highlight the disparities in access to HIV prevention for MSM SW living in these three countries during the COVID-19 pandemic. Based on our findings, COVID-19 may have exacerbated pre-existing inequities in HIV prevention among populations experiencing intersecting stigmas.

show abstract